DEF 14A

Company

Theriva Biologics, Inc.

Filed

April 29, 2008

Period of Report

June 3, 2008

Accession Number

0000890163-08-000299

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →